Xeltis
Manufacturing · Netherlands · 11-50 Employees
View Company Info for Free
Overview
Headquarters
31 De Lismortel, Eindhoven, Noord-Braban...Phone Number
+31407517614Website
www.xeltis.comRevenue
$10 MillionIndustry
About Xeltis
A clinical-stage medical device company, Xeltis has developed the most advanced polymer-based restorative devices for cardiovascular treatment. Xeltis' restorative devices comprise heart valves and small diameter blood vessels for coronary artery bypass graft (CABG) surgery and for hemodialysis vascular access. Xeltis was formed through the merger of two Dutch/Swiss university spin-offs and it currently has operations in The Netherlands and in the USA. Xeltis' investors include venture capital funds Kurma Partners, LSP, VI Partners and Ysios Capital as well as a number of private investors. CAUTION: The Xeltis technology is an investigational device and NOT approved for sale. 1Morales DL, Herrington C, Bacha EA, Morell VO, Prodán Z, Mroczek T, Sivalingam S, Cox M, Bennink G and Asch FM (2021) A Novel Restorative Pulmonary Valve Conduit: Early Outcomes of Two Clinical Trials.Explore more
SIC Code 38,384NAICS Code 33,339Show moreXeltis Org Chart
Xeltis Tech Stack
A closer look at the technologies used by Xeltis
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Xeltis
Sign Up For FreeTo access detailed company insights
A clinical-stage medical device company, Xeltis has developed the most advanced polymer-based restorative devices for cardiovascular treatment. Xeltis' restorative devices comprise heart valves and small diameter blood vessels for coronary artery bypass graft (CABG) surgery and for hemodialysis vascular access. Xeltis was formed through the merger... Read More